• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态治疗年轻患者转移性直肠癌:病例报告及文献复习。

Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review.

机构信息

Faculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania.

Medical Oncology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

出版信息

Medicina (Kaunas). 2024 Apr 24;60(5):696. doi: 10.3390/medicina60050696.

DOI:10.3390/medicina60050696
PMID:38792879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11123219/
Abstract

Metastatic colorectal cancer requires a multidisciplinary and individualized approach. Herein, we reported the case of a young woman diagnosed with metastatic rectal cancer who received an individualized multimodal treatment strategy that resulted in a remarkable survival. There were several particular aspects of this case, such as the early onset of the disease, the successful use of conversion therapy, the application of liquid biopsy to guide treatment, and the specific nature of the bone metastasis. To offer more insights for navigating such challenges in patients with metastatic colorectal cancer, we have conducted a literature review to find more data related to the particularities of this case. The incidence of early onset colorectal cancer is on the rise. Data suggests that it differs from older-onset colorectal cancer in terms of its pathological, epidemiological, anatomical, metabolic, and biological characteristics. Conversion therapy and surgical intervention provide an opportunity for cure and improve outcomes in metastatic colorectal cancer. It is important to approach each case individually, as every patient with limited liver disease should be considered as a candidate for secondary resection. Moreover, liquid biopsy has an important role in the individualized management of metastatic colorectal cancer patients, as it offers additional information for treatment decisions.

摘要

转移性结直肠癌需要多学科和个体化的治疗方法。在此,我们报告了一例年轻女性患有转移性直肠癌症的病例,她接受了个体化的多模式治疗策略,取得了显著的生存效果。该病例有几个特殊方面,例如疾病的早期发病、转化治疗的成功应用、液体活检在指导治疗中的应用以及骨转移的特异性。为了在转移性结直肠癌患者中遇到这些挑战时提供更多的见解,我们进行了文献复习,以找到更多与该病例特殊性相关的数据。早发性结直肠癌的发病率呈上升趋势。数据表明,其在病理、流行病学、解剖、代谢和生物学特征方面与老年发病的结直肠癌不同。转化治疗和手术干预为转移性结直肠癌患者提供了治愈的机会,并改善了预后。对每个病例进行个体化治疗非常重要,因为每个有限肝脏疾病的患者都应被视为二次切除的候选者。此外,液体活检在转移性结直肠癌患者的个体化管理中具有重要作用,因为它为治疗决策提供了额外的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/87527501c625/medicina-60-00696-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/aff6d4c18094/medicina-60-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/627f593aaf67/medicina-60-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/8cf732a601b9/medicina-60-00696-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/11c0887a0239/medicina-60-00696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/87527501c625/medicina-60-00696-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/aff6d4c18094/medicina-60-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/627f593aaf67/medicina-60-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/8cf732a601b9/medicina-60-00696-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/11c0887a0239/medicina-60-00696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5962/11123219/87527501c625/medicina-60-00696-g005.jpg

相似文献

1
Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review.多模态治疗年轻患者转移性直肠癌:病例报告及文献复习。
Medicina (Kaunas). 2024 Apr 24;60(5):696. doi: 10.3390/medicina60050696.
2
[A Case of Brain Metastasis from Rectal Cancer with Synchronous Liver and Lung Metastases after Multimodality Treatment--A Case Report].[1例直肠癌脑转移伴同步肝肺转移多模态治疗后的病例报告]
Gan To Kagaku Ryoho. 2015 Nov;42(12):1608-10.
3
[A Case of Resection for Metastatic Osseous Tumor from Rectal Cancer].[一例直肠癌骨转移瘤切除术病例]
Gan To Kagaku Ryoho. 2017 Nov;44(12):1874-1876.
4
Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.诊断时为IV期可切除疾病患者的原发性直肠癌。
Anticancer Res. 2007 Mar-Apr;27(2):1079-85.
5
Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.新辅助放化疗和根治性手术后局部晚期直肠癌的病理完全缓解可能低估远处转移:发生率、转移模式和危险因素。
Eur J Surg Oncol. 2019 Jul;45(7):1225-1231. doi: 10.1016/j.ejso.2019.03.005. Epub 2019 Mar 9.
6
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.多模式治疗伴有远处转移的肛管鳞状细胞癌:单机构经验
Dis Colon Rectum. 2017 Aug;60(8):785-791. doi: 10.1097/DCR.0000000000000827.
7
FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer.FOXFIRE方案:一项开放标签、随机、III期试验,研究5-氟尿嘧啶、奥沙利铂和亚叶酸(OxMdG)联合或不联合介入性选择性体内放射治疗(SIRT)作为不可切除的仅肝转移或肝转移为主的转移性结直肠癌患者的一线治疗方案。
BMC Cancer. 2014 Jul 9;14:497. doi: 10.1186/1471-2407-14-497.
8
Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.潜在可切除的转移性结直肠癌:转化治疗的个体化方法。
Crit Rev Oncol Hematol. 2014 Dec;92(3):218-26. doi: 10.1016/j.critrevonc.2014.05.010. Epub 2014 Jun 8.
9
INTRA-ARTERIAL CHEMOTHERAPY AS A CLINICAL OPTION FOR METASTATIC COLORECTAL CANCER: CONVERSION OF INOPERABLE LIVER METASTASES TO OPERABLE ILLUSTRATED WITH A CLINICAL CASE.经动脉化疗作为转移性结直肠癌的一种临床选择:不可切除肝转移转化为可切除——附 1 例临床病例。
Exp Oncol. 2024 Feb 3;45(4):515-522. doi: 10.15407/exp-oncology.2023.04.515.
10
Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.经动脉(化疗)栓塞与全身化疗治疗结直肠癌肝转移。
Cochrane Database Syst Rev. 2024 Aug 9;8(8):CD012757. doi: 10.1002/14651858.CD012757.pub2.

本文引用的文献

1
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.亚叶酸钙与氟尿嘧啶联合或不联合奥沙利铂作为晚期结直肠癌一线治疗方案
J Clin Oncol. 2023 Nov 20;41(33):5080-5089. doi: 10.1200/JCO.22.02773.
2
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.替氟尿苷替匹嘧啶与贝伐珠单抗治疗难治性转移性结直肠癌
N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963.
3
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines.
德尔菲早期结直肠癌倡议(DIRECT)国际管理指南。
Clin Gastroenterol Hepatol. 2023 Mar;21(3):581-603.e33. doi: 10.1016/j.cgh.2022.12.006. Epub 2022 Dec 20.
4
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.转移性结直肠癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2023 Jan;34(1):10-32. doi: 10.1016/j.annonc.2022.10.003. Epub 2022 Oct 25.
5
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.循环肿瘤 DNA 指导转移性结直肠癌重新使用 panitumumab:2 期 CHRONOS 试验。
Nat Med. 2022 Aug;28(8):1612-1618. doi: 10.1038/s41591-022-01886-0. Epub 2022 Aug 1.
6
Circulating tumor DNA and liquid biopsy in oncology.循环肿瘤DNA与肿瘤学中的液体活检
Nat Cancer. 2020 Mar;1(3):276-290. doi: 10.1038/s43018-020-0043-5. Epub 2020 Mar 20.
7
Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy.用于结直肠癌的精准医学:液体活检与免疫疗法
Cancers (Basel). 2021 Sep 25;13(19):4803. doi: 10.3390/cancers13194803.
8
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer.循环肿瘤细胞和循环肿瘤DNA作为液体活检标志物在结直肠癌中的临床应用
Cancers (Basel). 2021 Sep 7;13(18):4500. doi: 10.3390/cancers13184500.
9
Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study.对1086例芬兰转移性结直肠癌患者进行可切除性、临床行为及预后的重复集中多学科团队评估(RAXO):一项全国性前瞻性干预研究。
Lancet Reg Health Eur. 2021 Jan 29;3:100049. doi: 10.1016/j.lanepe.2021.100049. eCollection 2021 Apr.
10
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial.西妥昔单抗再挑战联合avelumab 治疗 RAS 野生型转移性结直肠癌预处理患者:单臂临床 CAVE 试验 2 期研究。
JAMA Oncol. 2021 Oct 1;7(10):1529-1535. doi: 10.1001/jamaoncol.2021.2915.